BRCA2 hereditary breast cancer pathophenotype

Joseph N. Marcus, Patrice Watson, David L. Page, Steven A. Narod, Patricia Tonin, Gilbert M. Lenoir, Olga Serova, Henry T. Lynch

Research output: Contribution to journalArticle

55 Scopus citations


Four BRCA2 hereditary breast cancer (HBC) families manifested significant excesses of 'tubular-lobular group' (TLG) invasive carcinomas and lobular carcinoma in situ/atypical lobular hyperplasia in comparison to BRCA1-HBC cases.

Original languageEnglish (US)
Pages (from-to)275-277
Number of pages3
JournalBreast Cancer Research and Treatment
Issue number3
StatePublished - Jul 28 1997

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'BRCA2 hereditary breast cancer pathophenotype'. Together they form a unique fingerprint.

  • Cite this

    Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Tonin, P., Lenoir, G. M., Serova, O., & Lynch, H. T. (1997). BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Research and Treatment, 44(3), 275-277.